BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5990189)

  • 1. [Treatment of essential hypertension with tocopherylquinone].
    Fontana L; Peschle C; Rengo F
    Clin Ter; 1966 Jun; 37(5):437-46. PubMed ID: 5990189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biological study of the application of alpha-tocopheryl-quinone for 5 years of primary and secondary muscular diseases and for 1 case of scleroderma].
    Turon R
    Sem Hop; 1968 Apr; 44(20):1375-9. PubMed ID: 4299465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attempts at treatment of amyotrophic lateral sclerosis].
    Domzal T; Ilnicki S
    Wiad Lek; 1974 Jun; 27(11):955-7. PubMed ID: 4839886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in vitamin E and D levels in patients with hypertensive disease during therapy].
    Mel'nichuk NI
    Vrach Delo; 1971 Aug; 8():37-9. PubMed ID: 5143059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial of Eutrophyl in dermatology].
    Géniaux M; Lamy J
    Bord Med; 1971 Mar; 4(3):945-8 passim. PubMed ID: 5575629
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTION OF TOCOPHERYLQUINONE IN ARTERIAL HYPERTENSION OF THE FIFTIES].
    GERAUD J; ARBUS L
    Toulouse Med; 1963 Nov; 64():1023-42. PubMed ID: 14094902
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new supportive therapy of certain progressive muscular dystrophies].
    Schmitt J
    Cah Med; 1972 Oct; 13(13):969-76. PubMed ID: 4642894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dioodobufenine in the treatment of essential arterial hypertension].
    Paladini G; Sgoifo E
    Minerva Cardioangiol; 1980 May; 28(5):303-8. PubMed ID: 7207819
    [No Abstract]   [Full Text] [Related]  

  • 9. [CLINICAL CONSIDERATIONS ON THE USE OF TOCOPHERYLQUINONE IN THE TREATMENT OF ARTERIAL HYPERTENSION].
    CAIRELLA M; VECCHI L
    Clin Ter; 1965 Mar; 32():500-14. PubMed ID: 14331666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of tiapamil, a new calcium antagonist, in the treatment of essential arterial hypertension].
    Nieto J; Gutiérrez Rodero F; Miranda B; Alcázar JM; Gutiérrez Millet V; Ruilope LM; Rodicio JL
    Med Clin (Barc); 1985 Jul; 85(6):225-7. PubMed ID: 4033283
    [No Abstract]   [Full Text] [Related]  

  • 11. [Triamterene (2,4,7-triamino-6-phenylpteridine) in the treatment of essential hypertension].
    Pippig L; Schmitt W; Buck R
    Arzneimittelforschung; 1965 Mar; 15(3):285-9. PubMed ID: 5897220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive effect of metoprolol in essential hypertension].
    Rodríguez Rodríguez FJ; Petersen Guitarte G; Paumard Fraguas A; López-Vidriero E; Franco Manera R
    Med Clin (Barc); 1983 Mar; 80(8):358-61. PubMed ID: 6855321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of cutaneous thermometry to the objectivation of effects of tocopheryl-quinone in muscular pathology].
    Balmes A; Piglowski J
    Therapeutique; 1970 Nov; 46(9):871-8. PubMed ID: 5495055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
    G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with hypertension with catapresan].
    Votchal BE; Kuchkina TS; Abramova VG
    Vrach Delo; 1972 Sep; 9():21-4. PubMed ID: 4658108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current views on the treatment of hypertension].
    Toker Y; Schmitz S
    Med Welt; 1966 Oct; 42():2244-50. PubMed ID: 5342040
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hypertension.
    Doyle AE
    N Y State J Med; 1968 Jan; 68(2):256-9. PubMed ID: 5235987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with endralazine in the treatment of essential hypertension].
    Dvorák I; Dvorák M; Blaha M; Kubesová H; Havlát F; Nĕmcová H
    Vnitr Lek; 1984 Jan; 30(1):42-7. PubMed ID: 6364562
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guanoxan (Comound 1003) in the treatment of arterial hypertension].
    Rapado Errazti A; Parra Lázaro J; Jiménez Casado M
    Rev Esp Cardiol; 1965 Oct; 18(4):455-62. PubMed ID: 5864947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.